表纸
市场调查报告书

Vichem Chemie Research Ltd.:产品平台分析

Vichem Chemie Research Ltd - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品编码 293923
出版日期 内容资讯 英文 32 Pages
订单完成后即时交付
价格
Back to Top
Vichem Chemie Research Ltd.:产品平台分析 Vichem Chemie Research Ltd - Product Pipeline Review - 2016
出版日期: 2016年12月30日内容资讯: 英文 32 Pages
简介

Vichem Chemie Research Ltd. 是致力于使用激酶抑制剂的信号传达疗法的研究开发的生物科技研究型企业。提供激化酵素抑制剂库,体外生物学,ADMET的最佳化,药物发明标的蛋白质的提高等,各种服务。

这份报告提供Vichem Chemie Research Ltd.的治疗药开发平台的现状及各开发阶段比较分析、各药物标的、作用机制、给药途径、分子类型的治疗药的评估、后期阶段及中止的计划相关资讯等。

Vichem Chemie Research Ltd.的基本资料

  • Vichem Chemie Research Ltd.概要
  • 主要资讯
  • 企业资料

Vichem Chemie Research Ltd.:R&D概要

  • 主要的治疗范围

Vichem Chemie Research Ltd.:开发平台的检讨

  • 各开发阶段的开发中产品
  • 单剂产品
  • 合作伙伴产品
    • 合作伙伴产品/联合治疗模式

Vichem Chemie Research Ltd.:开发中产品概况

  • 初期阶段的开发中产品
    • 前临床阶段的产品/联合治疗模式
    • 药物研发中的产品/联合治疗模式

Vichem Chemie Research Ltd.:药物简介

  • 中枢神经系统、自体免疫疾病小分子
  • HIV-第一型感染疾病 CDK9 抑制小分子
  • VID-45110
  • BBH-7
  • BTP-15
  • 未公布的症状的 VEGFR2 拮抗小分子
  • 非小细胞肺癌、肺腺癌的 EGFR 阻碍细分
  • 急性骨髓白血病的 FLT3 抑制小分子
  • 癌症、细菌感染疾病 的PLK1 抑制小分子
  • 未公布的症状的 ROCK2 抑制小分子
  • 慢性心脏疾病的小分子
  • 大肠菌感染疾病的小分子
  • 多发性骨髓瘤的小分子
  • 肿瘤学的 HGFR/EGFR 拮抗小分子
  • 肿瘤学的 Pan FGFR 拮抗小分子
  • 肿瘤学的 PDGFR-beta 拮抗小分子
  • 肿瘤学的Aurora-A激酶 抑制小分子
  • 肿瘤学的Aurora-B激酶 抑制小分子
  • 肿瘤学的抑制小分子 CDK4
  • VCC-405567
  • VCC-668662

Vichem Chemie Research Ltd.:开发平台分析

  • 各标靶
  • 各分子类型
  • 各作用机制

Vichem Chemie Research Ltd.:暂停中的计划

Vichem Chemie Research Ltd.:总公司和子公司的所在地

附录

图表一览

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GMDHC08198CDB

Summary:

Global Markets Direct's, 'Vichem Chemie Research Ltd - Product Pipeline Review - 2016', provides an overview of the Vichem Chemie Research Ltd's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Vichem Chemie Research Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

  • The report provides a snapshot of the pipeline therapeutic landscape of Vichem Chemie Research Ltd
  • The report provides overview of Vichem Chemie Research Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Vichem Chemie Research Ltd's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Vichem Chemie Research Ltd's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy:

  • Evaluate Vichem Chemie Research Ltd's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Vichem Chemie Research Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Vichem Chemie Research Ltd's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Vichem Chemie Research Ltd Snapshot
    • Vichem Chemie Research Ltd Overview
    • Key Facts
  • Vichem Chemie Research Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Vichem Chemie Research Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Vichem Chemie Research Ltd - Pipeline Products Glance
    • Vichem Chemie Research Ltd - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Vichem Chemie Research Ltd - Drug Profiles
    • BBH-7 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • BTP-15 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecule for Oncology - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecule for Tuberculosis - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small molecule to Inhibit FLT3 for Acute Myeloid Leukemia - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules for Melanoma - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules to Inhibit CDK9 for HIV-1 Infection - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules to Inhibit IRS-1 for Type 2 Diabetes - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules to Inhibit Pan FGFR for Oncology - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • VCC-234718 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Vichem Chemie Research Ltd - Pipeline Analysis
    • Vichem Chemie Research Ltd - Pipeline Products by Target
    • Vichem Chemie Research Ltd - Pipeline Products by Molecule Type
    • Vichem Chemie Research Ltd - Pipeline Products by Mechanism of Action
  • Vichem Chemie Research Ltd - Dormant Projects
  • Vichem Chemie Research Ltd - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Vichem Chemie Research Ltd, Key Facts
  • Vichem Chemie Research Ltd - Pipeline by Indication, 2016
  • Vichem Chemie Research Ltd - Pipeline by Stage of Development, 2016
  • Vichem Chemie Research Ltd - Monotherapy Products in Pipeline, 2016
  • Vichem Chemie Research Ltd - Partnered Products in Pipeline, 2016
  • Vichem Chemie Research Ltd - Partnered Products/ Combination Treatment Modalities, 2016
  • Vichem Chemie Research Ltd - Preclinical, 2016
  • Vichem Chemie Research Ltd - Discovery, 2016
  • Vichem Chemie Research Ltd - Pipeline by Target, 2016
  • Vichem Chemie Research Ltd - Pipeline by Molecule Type, 2016
  • Vichem Chemie Research Ltd - Pipeline Products by Mechanism of Action, 2016
  • Vichem Chemie Research Ltd - Dormant Developmental Projects,2016

List of Figures

  • Vichem Chemie Research Ltd - Pipeline by Top 10 Indication, 2016
  • Vichem Chemie Research Ltd - Pipeline by Stage of Development, 2016
  • Vichem Chemie Research Ltd - Monotherapy Products in Pipeline, 2016
  • Vichem Chemie Research Ltd - Pipeline by Target, 2016
  • Vichem Chemie Research Ltd - Pipeline by Molecule Type, 2016
  • Vichem Chemie Research Ltd - Pipeline Products by Mechanism of Action, 2016
Back to Top